Is IO Biotech Inc halal to invest in?

According to Musaffa's Shariah screening methodology, IO Biotech Inc (IOBT) is currently classified as NOT HALAL as of November 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is IO Biotech Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes IO Biotech Inc using these criteria to determine its compliance status.

Can Muslims buy shares of IO Biotech Inc?

Muslim investors may consider investing in IO Biotech Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is IO Biotech Inc classified as NOT HALAL?

Musaffa determines the Shariah status of IO Biotech Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for IO Biotech Inc updated?

The Shariah compliance status of IO Biotech Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like IO Biotech Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of IO Biotech Inc?

You can check the latest Shariah compliance status of IO Biotech Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

IOBT Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: November 24, 2025

Report Source: 2025 3rd Quarter Report

Analyst's Ratings for IO Biotech Inc (IOBT)

Based on 10 analysts giving stock ratings to IO Biotech Inc in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

IO Biotech Inc. Stock Analysis IOBT

United States Health Care Nano Cap Report: Q3, 2025

IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. The firm develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. The firm is spin-off of National Cancer for Center Immune Therapy at Herlev University Hospital in Denmark.

Key Statistics of IO Biotech Inc (IOBT)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.03$0.06

Today's Open

$0.03

Volume

266.98K

P/E Ratio (TTM)

52 Week Range

$0.03$2.79

Market Cap

13.74M

Avg. Volume

723.28K

Dividend Yield

Financial Metrics & Statements of IO Biotech Inc (IOBT)

FAQ's for IO Biotech Inc (IOBT)

According to Musaffa’s Shariah screening methodology, IO Biotech Inc (IOBT) is currently classified as NOT HALAL as of November 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.